Dexlansoprazole
Active substance: dexlansoprazole
CAPSULE, DELAYED RELEASE · DEXLANSOPRAZOLE 30 mg/1
United StatesActive
Marketing holder: Alembic Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DEXLANSOPRAZOLE · 30 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-297a-7709-a2ad-acdb1007eb27,01a1208c-6297-7881-98bb-1aa4743711ec,01a1208c-6596-7dac-aad8-30c636141038,01a1208d-0275-7ab9-b2ab-4aa0f978b3ad,01a1208e-4f07-7b91-a5f1-96b6a5ca1350;count=20 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 62332-823
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 62332-823 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 62332-823 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 62332-823 · Verified 2026-10-09 · open in source